Aparna Sahoo
About Aparna Sahoo
Current Role as VP, Head of Global Clinical Development
Aparna Sahoo currently serves as the Vice President and Head of Global Clinical Development. In this role, she oversees the strategic direction and execution of clinical development programs on a global scale. Her responsibilities include leading cross-functional teams to advance the pipeline of therapeutic candidates, focusing on Nephrology and Immunology.
Professional Background in Nephrology and Immunology
Aparna Sahoo brings a significant amount of experience in global clinical development, particularly in the fields of Nephrology and Immunology. Prior to her current role, she held leadership positions at Johnson & Johnson, AstraZeneca, Allergan, and Parexel. Her extensive career includes leading a Phase 3 global clinical development program for Tremfya in inflammatory bowel disease at Janssen (Johnson & Johnson Innovative Medicine), dealing with both biologic and device development.
Medical Experience and Board Certifications
Aparna Sahoo is a board-certified internist and nephrologist. She practiced medicine for 12 years in central New Jersey, working in both academic and private practice settings. Her clinical expertise in internal medicine and nephrology has been foundational to her roles in clinical development.
Educational Background in Medicine
Aparna Sahoo completed her medical residency in internal medicine at Rutgers-Robert Wood Johnson Medical School located in New Brunswick, New Jersey. She then pursued a nephrology fellowship at New York Medical College in Valhalla, New York. Her education has equipped her with a strong medical background and specialized knowledge in nephrology.